COMP <GO>
SRTA vs SBC // 10Y YIELD & FRED MACRO BETA
Strata Critical Medical Inc. (Class A) (NASDAQ) VS. SBC Medical Group Holdings Incorporated (NASDAQ) • 15-METRIC TALLY: SRTA 3
— SBC 8
■ METRIC PARITY
LAST: $4.44 (-6.53%) • MKT CAP: $420.2M
macro-sensitivity
—
LAST: $5.28 (-7.29%) • MKT CAP: $585.2M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRTA VS. SBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRTA | SBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.90% | 73.30% | -52.40 | SBC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.10% | 63.10% | -70.20 | SBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.92% | 3.98% | -17.90 | SBC | /fcf-yield <GO> |
| Operating Margin | -11.30% | 38.90% | -50.20 | SBC | /operating-margins <GO> |
| Net Profit Margin | 21.00% | 29.40% | -8.40 | SBC | /net-margins <GO> |
| Revenue Growth (YoY) | 34.30% | -15.50% | +49.80 | SRTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.58 | 5.46 | +0.12 | SRTA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | SBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 59.6 | -10.50 | SBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 10.7x | -2.10 | SRTA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $420.2M | $585.2M | -$165.0M | SBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRTA REV | SBC REV | SRTA GROSS % | SBC GROSS % | SRTA FCF | SBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $197.1M | $173.6M | 20.9% | 73.3% | -$58.5M | $23.3M |
| FY 2024 | $146.8M | $205.4M | 20.2% | 76.0% | -$33.4M | $18.0M |
| FY 2023 | $225.2M | $193.5M | — | — | -$32.3M | $50.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRTA // BETA —
SBC // BETA —